SYRE: Combination antibody therapies in autoimmune diseases advance toward pivotal global trials
Focused on advancing combination antibody therapies for autoimmune diseases, the pipeline targets IBD, rheumatology, and dermatology, with global trials and a strong financial position. Key readouts this year and next will guide phase III priorities, aiming for products that outperform current stan…